Focus on Psychosis

Page 2

Recently published articles about Focus on Psychosis

JCP
Predictors for Initiation of LAIs in Individuals With Early-Phase Schizophrenia
Original Research

February 13, 2023

Initiation of LAIs was predicted by greater switching of oral antipsychotics and more ED visits. LAIs are often used to respond to relapse rather than prevent it.
, , , et al
JCP
Antipsychotic Dose and Weight Gain
Meta-Analysis

February 8, 2023

Although effects on weight gain have been explored for several antipsychotics, the role of dose in producing these effects has not been widely studied. This meta-analysis examined the association...
, , , et al
JCP
Telehealth of CSC in Early Psychosis During COVID-19
Original Research

November 30, 2022

As the COVID-19 pandemic emerged in 2020, access to in-person clinical care was restricted. This study explored if transition of coordinated specialty care to telehealth for psychosis patients allowed...
, , , et al
JCP
Economic Burden of Schizophrenia in the US
Original Research

October 10, 2022

Schizophrenia is associated with significant economic burden, not only for patients but also for families, other caregivers, and the wider society. This study analyzed recent data and literature to...
, , , et al
JCP
Add-on Pramipexole for Schizophrenia
Original Research

August 1, 2022

Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...
, , , et al
JCP
Long-term Outcomes of Early Use of LAIs in Schizophrenia
Original Research

June 1, 2022

Using data from the Taiwan National Health Insurance Research Database, the authors compared long-term effectiveness of switching to long-acting injectable antipsychotics versus remaining on oral antipsychotics.
, ,

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe